RYZB RayzeBio Inc.

About RYZB

Rayzebio, Inc. provides radiopharmaceutical medicines for cancer. It develops a pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225. The company was founded by Deborah Charych, Aaron Kantoff and Aron Royston in January 2020 and is headquartered in San Diego, CA.
42

Bearish Sentiment

How do you feel about RYZB?

Advertisement|Remove ads.